| [1] Zhou K,Qiao K,Edgar S,et al. Distributing a metabolic pathway among a microbial consortium enhances production of natural products. Nat Biotechnol,2015,33(4):377-383.
[2] Xie W,Lv X,Ye L,et al. Construction of lycopene-overproducing Saccharomyces cerevisiae by combining directed evolution and metabolic engineering. Metab Eng,2015,30:69-78.
[3] Paddon C J,Keasling J D. Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development. Nat Rev Microbiol,2014,12(5):355-367.
[4] Szczebara F M,Chandelier C,Villeret C,et al. Total biosynthesis of hydrocortisone from a simple carbon source in yeast. Nat Biotechnol,2003,21(2):143-149.
[5] Duport C,Spagnoli R,Degryse E,et al. Self-sufficient biosynthesis of pregnenolone and progesterone in engineered yeast. Nat Biotechnol,1998,16(2):186-189.
[6] Parks L W,Casey W M. Physiological implications of sterol biosynthesis in yeast. Annu Rev Microbiol,1995,49:95-116.
[7] Veen M,Stahl U,Lang C. Combined overexpression of genes of the ergosterol biosynthetic pathway leads to accumulation of sterols in Saccharomyces cerevisiae. FEMS Yeast Res,2003,4(1):87-95.
[8] Polakowski T,Stahl U,Lang C. Overexpression of a cytosolic hydroxymethylglutaryl-CoA reductase leads to squalene accumulation in yeast. Appl Microbiol Biotechnol,1998,49(1):66-71.
[9] Hull C M,Loveridge E J,Rolley N J,et al. Co-production of ethanol and squalene using a Saccharomyces cerevisiae ERG1 (squalene epoxidase) mutant and agro-industrial feedstock. Biotechnol Biofuels,2014,7(1):133.
[10] Milla P,Athenstaedt K,Viola F,et al. Yeast oxidosqualene cyclase (Erg7p) is a major component of lipid particles. J Biol Chem,2002,277(4):2406-2412.
[11] Martel C M,Parker J E,Warrilow A G,et al. Complementation of a Saccharomyces cerevisiae ERG11/CYP51 (sterol 14alpha-demethylase) doxycycline-regulated mutant and screening of the azole sensitivity of Aspergillus fumigatus isoenzymes CYP51A and CYP51B. Antimicrob Agents Chemother,2010,54(11):4920-4923.
[12] Shah-Alam-Bhuiyan M,Eckstein J,Barbuch R,et al. Synthetically lethal interactions involving loss of the yeast ERG24: the sterol C-14 reductase gene. Lipids,2007,42(1):69-76.
[13] Gachotte D,Sen S E,Eckstein J,et al. Characterization of the Saccharomyces cerevisiae ERG27 gene encoding the 3-keto reductase involved in C-4 sterol demethylation. Proc Natl Acad Sci USA,1999,96(22):12655-12660.
[14] Baudry K,Swain E,Rahier A,et al. The effect of the erg26-1 mutation on the regulation of lipid metabolism in Saccharomyces cerevisiae. J Biol Chem,2001,276(16):12702-12711.
[15] Nose H,Miyara T,Kushida N,et al. Isolation of temperature-sensitive Saccharomyces cerevisiae with a mutation in erg25 for C-4 sterol methyl oxidase. J Antibiot (Tokyo),2002,55(11):962-968.
[16] Kaneshiro E S,Johnston L Q,Nkinin S W,et al. Sterols of Saccharomyces cerevisiae erg6 knockout mutant expressing the Pneumocystis carinii S-adenosylmethionine: sterol C-24 methyltransferase. J Eukaryot Microbiol,2015,62(3):298-306.
[17] Ruan B,Lai P S,Yeh C W,et al. Alternative pathways of sterol synthesis in yeast. Use of C(27) sterol tracers to study aberrant double-bond migrations and evaluate their relative importance. Steroids,2002,67(13-14):1109-1119.
[18] Morio F,Pagniez F,Lacroix C,et al. Amino acid substitutions in the Candida albicans sterol Delta5,6-desaturase (Erg3p) confer azole resistance:characterization of two novel mutants with impaired virulence. J Antimicrob Chemother,2012,67(9):2131-2138.
[19] Zweytick D,Hrastnik C,Kohlwein S D,et al. Biochemical characterization and subcellular localization of the sterol C-24(28) reductase,erg4p,from the yeast Saccharomyces cerevisiae. FEBS Lett,2000,470(1):83-87.
[20] Carlberg C. Genome-wide (over)view on the actions of vitamin D. Front Physiol,2014,5:167.
[21] Lehmann U,Hirche F,Stangl G I,et al. Bioavailability of vitamin D(2) and D(3) in healthy volunteers,a randomized placebo-controlled trial. J Clin Endocrinol Metab,2013,98(11):4339-4345.
[22] Keasling J D. Manufacturing molecules through metabolic engineering. Science,2010,330(6009):1355-1358.
[23] Dahl R H,Zhang F,Alonso-Gutierrez J,et al. Engineering dynamic pathway regulation using stress-response promoters. Nat Biotechnol,2013,31(11):1039-1046.
[24] Su W,Xiao W H,Wang Y,et al. Alleviating redox imbalance enhances 7-Dehydrocholesterol production in engineered Saccharomyces cerevisiae. PloS One,2015,10(6):e0130840.
[25] Gray G W,McDonnell D G. Synthesis and liquid crystal properties of chiral alkyl-cyano-biphenyls (and -p-terphenyls) and of some related chiral compounds derived from biphenyl. Mol Cryst Liq Cryst,1976,37(1):189-211.
[26] Confalone P N,Kulesha I D,Uskokovic M R. A new synthesis of 7-dehydrocholesterol. J Org Chem,1981,46(5):1030-1032.
[27] Bell M C,Schmidt-Grimminger D C,Connor M G,et al. A cervical teratoma with invasive squamous cell carcinoma in an HIV-infected patient: a case report. Gynecol Oncol,1996,60(3):475-479.
[28] Lian J,Si T,Nair N U,et al. Design and construction of acetyl-CoA overproducing Saccharomyces cerevisiae strains. Metab Eng,2014,24:139-149.
[29] Lang C,Markus V. Preparation of 7-dehydrocholesterol and/or the biosynthetic intermediates and/or secondary products thereof in transgenic oganisms. US Patent,12607017,2011-07-23.
[30] Hohmann H P,Lehmann M,Merkamm M. Production of non-yeast sterols by yeast. US Patent,20120231495,2012-09-13.
[31] Lin Q,Jia B,Mitchell L A,et al. RADOM,an efficient in vivo method for assembling designed DNA fragments up to 10 kb long in Saccharomyces cerevisiae. ACS Synth Biol,2015,4(3):213-220.
[32] Gietz R D,Schiestl R H. High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method. Nat Protoc,2007,2(1):31-34.
[33] Acimovic J,Rozman D. Steroidal triterpenes of cholesterol synthesis. Molecules,2013,18(4):4002-4017.
[34] Zerenturk E J,Sharpe L J,Ikonen E,et al. Desmosterol and DHCR24: unexpected new directions for a terminal step in cholesterol synthesis. Prog Lipid Res,2013,52(4):666-680. |
